Antipsychotic-Induced Rabbit Syndrome: Epidemiology, Management and Pathophysiology

ISSN： 1172-7047

Source： CNS Drugs, Vol.18, Iss.4, 2004-01, pp. : 213-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Management of Atypical Antipsychotic-Induced Weight Gain

By Baptista Trino

CNS Drugs, Vol. 22, Iss. 6, 2008-01 ,pp. : 477-495

Adis International

Access to resources Recommend Favorite

Antipsychotic-Induced Hyperprolactinaemia: Mechanisms, Clinical Features and Management

By Peter M. Haddad Angelika Wieck

Drugs, Vol. 64, Iss. 20, 2004-01 ,pp. : 2291-2314

Adis International

Access to resources Recommend Favorite

Guillain-Barré Syndrome: Epidemiology, Pathophysiology and Management

By Kuwabara S.

Drugs, Vol. 64, Iss. 6, 2004-01 ,pp. : 597-610

Adis International

Access to resources Recommend Favorite

Antipsychotic-Induced Movement Disorders in the Elderly: Epidemiology and Treatment Recommendations

By Caligiuri M.P.

Drugs & Aging, Vol. 17, Iss. 5, 2000-11 ,pp. : 363-384

Adis International

Access to resources Recommend Favorite

Risperidone-induced rabbit syndrome: an unusual movement disorder caused by an atypical antipsychotic

By Levin T. Heresco-Levy U.

European Neuropsychopharmacology, Vol. 9, Iss. 1, 1999-01 ,pp. : 137-139

Elsevier

Access to resources Recommend Favorite